Key result
Genetic analysis of dilated cardiomyopathy identifies multiple associated genes and suggests dystrophin may provide a common pathway in the pathogenesis of cardiomyopathies.
Answers are grounded in this paper and cite their sources.
This review summarizes the genetic basis of dilated cardiomyopathy, highlighting the potential role of dystrophin as a common pathogenic pathway.
Cardiomyopathies are disorders affecting heart muscle which usually result in inadequate pumping of the heart and are the most common cause of heart failure. Dilated cardiomyopathy (DCM) causes ventricular dilation and dysfunction, primarily of the left ventricle, and has many etiologies. Genetic heterogeneity exists and several of these genes are now known, including dystrophin, cardiac actin, desmin, δ-sarcoglycan, cardiac troponin T, β-myosin heavy chain, α-tropomyosin, titin and metavinculin. Here I will review the identification of genes associated with DCM and data demonstrating that dystrophin may provide a common pathway in the pathogenesis of cardiomyopathies.
No takes yet. Share an insight, caveat, or question.
Neil E. Bowles (2002) conducted a review in Dilated cardiomyopathy. Genetic analysis of dilated cardiomyopathy identifies multiple associated genes and suggests dystrophin may provide a common pathway in the pathogenesis of cardiomyopathies.
Synapse has enriched 10 related papers. Consider them for comparative context: